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ABSTRACT  
 
Organic and inorganic compounds are present as contaminants in varying concentrations 
throughout our water cycle. Examples of these contaminants include the endocrine disrupting 
compounds (EDCs) bisphenol-A (BPA) and 17β-estradiol (E2) from plastics and pharmaceutical 
use. It can be necessary to obtain the concentration of these compounds within the water cycle 
for analysis by interested parties such as research groups, regulatory agencies, and private 
organizations. These concentrations, however, can be too dilute within the initial sample for 
analysis. Therefore it is necessary to concentrate the compound of interest (analyte) prior to 
analysis. One such way to do this is by way of Solid Phase Extraction (SPE). 
SPE uses a small cartridge which contains chromatographic packing material to 
chemically extract analytes from a water sample onto a solid phase. To increase concentration, 
these analytes are then transferred (eluted) to a substantially smaller volume of organic solvent 
for eventual analyses. These commercially available cartridges are relatively inexpensive, 
approximately $5 each. However, these cartridges are labeled as single use. In large-scale 
analyses, this can quickly add up to a sizable percentage of the analysis budget. Additionally, 
sizable waste volumes can be generated from these analyses in the form of non-degradable 
polypropylene plastic. If these cartridges can be re-used, material costs as well as waste volumes 
can be substantially reduced. However, little is known regarding how the quality of analysis 
degrades with cartridge re-use. The objective of this project is to evaluate the number of times 
SPE cartridges can be reused without compromising the results of the subsequent analyses. 
 vi 
 
Based on a review of prior literature, I identified and developed protocols for extracting 
analytes (BPA and E2) from water via SPE, then analyzing them with gas chromatography and 
mass spectrometry (GC-MS). These protocols have been developed to mimic those employed by 
research labs, industry, and other entities for which the results of this study would be most 
applicable. The only deviation is the re-use of the cartridge rather than disposal and replacement. 
One type of commercially available SPE cartridge (Oasis HLB, Waters Inc., Milford, MA) was 
used and two water types were tested.  The water was spiked with fixed concentrations of BPA 
and E2, and then analyzed by way of SPE/GC-MS. For both water types, I performed multiple 
SPE runs on 10 cartridges each. I tracked the history of GC-MS peak areas, which indicate 
apparent analyte concentration. Peak area data were analyzed as a function of the number of 
analyses performed (run number), and evaluated for statistically significant changes as well as 
overall trends.  Statistically significant change and/or trends would indicate that the cartridge had 
exceeded the maximum allowable number of re-uses and would thereby identify the number of 
times the “single-use” cartridge can reliably be re-used. 
 Peak area history for 20 SPE runs per cartridge for pure water samples and 10 SPE runs 
for wastewater effluent showed no statistically significant changes or trends on peak area. This 
indicates that cartridges can be re-used at least 10 times without compromising the integrity of 
water sample analysis for the EDCs considered in this study.
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CHAPTER 1: INTRODUCTION 
  
Organic and inorganic compounds are present as contaminants in varying concentrations 
throughout our water cycle. Some major pollutant types include solvents, heavy metals, salts, 
minerals, fertilizers and nutrients, pesticides, petroleum distillates, pharmaceuticals and personal 
care compounds (PPCPs), and plasticizers. Heavy metals, salts, and minerals are examples of 
inorganic pollutants [1]. PPCPs and plasticizers are examples of organic pollutants [2]. Certain 
pollutants are further classified as Endocrine Disrupting Compounds (EDCs) due to their 
interference with the body’s endocrine system. Two examples of EDCs are the plasticizer 
bisphenol-A (BPA), used in the manufacturing of plastics, and 17β-estradiol (E2), used in 
pharmaceutical products [3]. A wide variety of health effects have been linked to these 
contaminants [4]. For instance, EDCs have been linked to human reproductive abnormalities [5], 
reduced testosterone production and reduced sperm counts in male rats [6], long-term impacts on 
intellectual functions in children [7], delayed effects on central nervous system functions in 
infants [8], as well as skewed gender ratio distribution in crustaceans [9], fish [3], and rats [10].  
To protect public health, concentrations of pollutants are evaluated and monitored within 
the water cycle. This can be done by interested parties such as research groups, regulatory 
agencies, and private organizations. Typically concentrations of EDCs in water are measured 
using analytical instruments such as gas chromatography with mass spectrometry (GC-MS) or 
liquid chromatography with mass spectrometry (LC-MS) [11]. However, concentrations of EDCs 
can be too dilute within the initial sample for analysis. Therefore, it is necessary to concentrate 
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the compound of interest (analyte) prior to analysis. One such way to do this is by way of solid-
phase extraction (SPE) [11].  
SPE uses a chromatographic packing material within the column of a small cartridge 
which chemically extracts analytes from solution, transferring the analytes from the aqueous 
phase to the solid phase [12]. These analytes, once concentrated within this cartridge column, 
can then be eluted by a substantially smaller volume of organic solvent [13]. The net result is a 
transfer of the analytes from a large volume of aqueous sample at a low concentration to a small 
volume of organic solvent at a higher concentration. Methods following the SPE process, such as 
chemical derivatization, can be employed to further prepare the analytes for analysis [13]. The 
final analysis of the compounds is typically performed using either LC-MS or GC-MS depending 
on the nature of the chemical [13].  
SPE is used to prepare samples for GC-MS or LC-MS analysis in a wide variety of 
applications. Examples of these applications include: analysis of human plasma [14]; 
determining E2 concentrations in drinking water [3]; analysis of BPA levels in body fluids and 
tissues derived from individuals exposed to the wastewater of polycarbonate plastic production 
[15]. 
A central component to the SPE method is the cartridge. This commercially available 
device is relatively inexpensive, approximately $5 to $10 each. However, these cartridges are 
labeled as single use. For instance, the SPE cartridge manufacturer Waters lists on their website 
(http:// http://www.waters.com ) “these SPE cartridges are intended for single use only”. In 
large-scale analyses, this can quickly add up to an appreciable cost. Additionally, sizable waste 
volumes can be generated from these analyses in the form of non-degradable polypropylene 
plastic.  
 3 
 
Large-scale analyses using SPE have associated large costs and large waste volumes. 
Following are two hypothetical scenarios in which SPE is used. Both of these scenarios were 
based on real data provided to me by two US water laboratories (asking to remain anonymous) 
from within the industry. For example, take a large regional laboratory. They have good 
equipment, well-trained staff, and an efficient SPE system so unnecessary cartridge waste is 
minimized. They may use approximately 1,500 cartridges per year and pay $5 per cartridge. This 
translates to approximately $7,500 total cost and 1,500 cartridges disposed of per year. Now take 
a small mobile laboratory. Their SPE Standard Operating Procedure is a little out of date and 
inefficient, so for every cartridge used there is one extra cartridge wasted. This laboratory tests 
between 250-500 samples per year. Because of the extra cartridge waste they, instead, use 500-
1,000 cartridges per year. Due to the laboratory’s small size, they pay more for their cartridges; 
approximately $15/ ea. Therefore this small scale laboratory, per year, is spending $7,500-
$15,000 on SPE cartridges and throwing away 500-1000 cartridges.  
If these cartridges can be re-used without sacrificing or compromising the reliability of 
the analysis, material costs as well as waste volumes can be substantially reduced. However, 
little is known regarding how the quality of analysis degrades with cartridge re-use. One study 
found that SPE disks (similar to SPE cartridges) could be used four times in the preparation of 
samples for analysis of pyrethroid pesticides by gas chromatography with electron capture 
detection (GC-ECD) [16]. However, reuse analysis was limited to no more than four times; any 
reuse above four times was not investigated [16]. Additionally, the study was limited to one type 
of analyte (pyrethroid), one type of SPE medium (C18 disks), and one type of water [16]. To the 
best of my knowledge, this is the only study that has examined the potential for re-use of SPE 
devices. 
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Therefore, the overall objective of this thesis is to determine how many times selected 
SPE cartridges can be reused to prepare samples for chemical analysis. Specifically, I used Oasis 
HLB ® cartridges (Waters Inc., Milford, MA) to prepare two types of water samples (purified 
water and final treated wastewater from a wastewater treatment plant) spiked with known 
concentrations of BPA and E2. I evaluated the water samples using GC-MS and looked for 
statistically significant deviations in the results in order to determine if the cartridges can be re-
used and, if so, how many times. For each water type, results were compared based on cartridge 
run number for the two analytes and control standard. The successful completion of this project 
will enable laboratories to simultaneously provide high quality data while reducing waste and 
saving money.  
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CHAPTER 2: MATERIALS AND METHODS 
  
2.1 Overview 
In order to address the objective of this paper, which is to determine the reusability of the 
SPE cartridge, single-use cartridges were used and reused under application of a standard SPE 
procedure. I used 10 cartridges for spiked purified water, running each 20 times. I also used 10 
cartridges for spiked treated wastewater, running each 10 times. Samples obtained from this SPE 
procedure were analyzed using GC-MS, which produced chromatograms with peak areas 
representing analyte concentrations. The peak areas were evaluated for any statistically 
significant deviation between reuse. The point at which values were found to significantly 
deviate indicated when a cartridge began showing signs of failure. 
2.2 Materials 
2.2.1 SPE Cartridges 
This analysis uses a 150 mg HLB SPE cartridge with a barrel volume of 6 mL. The 
manufacturer was Oasis (Milford, MA) with a part number 186003365. 
2.2.2 Chemicals 
This analysis used the chemicals listed in Table 2.1 for stock preparation, sample 
preparation, and analysis. Figure 2.1 is the chemical structure of BPA and Figure 2.2 is the 
chemical structure of E2. 
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Table 2.1: Chemicals used in this analysis 
 
 
Figure 2.1: Chemical structure of bisphenol A 
 
Figure 2.2: Chemical structure of estradiol 
2.2.3 Water Tested 
This analysis used deionized water and wastewater effluent. The water was prepared as 
described in the following two sections. 
2.2.4 Purified/Deionized (DI) Water 
The Environmental Engineering laboratory at the University of South Florida (USF) has 
access to deionized water, purified on-site as follows. Raw tap water initially hits a 1 μm filter. It 
Chemical Purity (%) Manufacture Location Part Number
Bisphenol A (BPA) 99 Sigma Aldrich St. Louis, MO 239658-50G
17β Estradiol (E2) 98 Sigma Aldrich St. Louis, MO E8875-250MG
4-Nonylphenol 99 Acros Geel, Belgium 416240010
BSTFA-TMCS* n/a Fluka Metropolis,IL 15238-5ML
Methanol 99.9 Fisher Waltham, MA A412-4
Nitrogen gas 99.5 Airgas Tampa, FL NI300
*N,O-bis(Trimethylsilyl)trifluoroacetamide with Trimethylchlorosilane 
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is then run through activated carbon tanks for chlorine and organic removal. It then goes through 
a mixed bed deionization tank to remove ions, then through a mixed bed deionization polishing 
tank. Following, it hits a 50.8 cm 0.2 μm filter for bacterial control. Finally, UV light (200 nm 
wavelength lamp) is used for any remaining bacterial control. The system operates in a loop, 
travelling from the purification system, out into the laboratory to the DI tap where DI water can 
be dispensed, and any unused DI water is sent back to the purification system to be treated again. 
The system is maintained by Purification Technologies. 
Table 2.2: Components of the DI purification system 
 
2.2.5 Wastewater Effluent 
Wastewater effluent was collected from the Howard F. Curren Advanced Wastewater 
Treatment Plant in Tampa, Florida. The treated wastewater was collected after the denitrification 
filtration process and before disinfection. Directly prior to sample preparation, the treated 
wastewater was filtered using 0.22μm membrane filters (Millipore; item # GVWP04700). 
2.3 Stock and Sample Preparation Method 
An initial stock solution containing the analytes must be created prior to any SPE runs. 
All samples used in the SPE runs are prepared using this stock solution so as to maintain 
consistent initial analyte concentrations throughout the data set. Procedures to create this stock 
solution can be found in Table 2.3a and procedures to prepare the water samples can be found in 
Table 2.3b. The SPE method in section 2.4 discusses the use of an internal standard. The 
procedure to create the internal standard stock solution can be found in Table 2.3c. 
Component Manufacturer Location Part Number
Mixed bed deionization tank Structural Milwaukee, WI 1047200811060120
Carbon filter tank Structural Milwaukee, WI CH30546-10010102-10
Micro-filter (rating 0.2, 20" length) Global Port Washington, NY GHPS0.2A20C16S
UV Water Purifier Mighty Pure Hauppauge, NY MP36C
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Table 2.3a: BPA and E2 stock solution preparation 
 
Table 2.3b: Aqueous sample preparation 
 
Table 2.3c: Internal standard stock solution preparation 
 
2.4 SPE Method 
The SPE procedure employed in this study was designed to mimic as closely as possible 
that which may be found in a typical water quality or commercial lab in order to increase the 
relevance and applicability of this study’s results. Method steps were compiled by way of an 
extensive literature review [11,12,16–25], consultation with field experts, and interviews with 
commercial lab managers as well as a review of their SPE lab procedure documents. Table 2.4 
gives a breakdown of each method step, and its objectives. 
 
 
Solution Soution Type
1. Bisphenol A (BPA)
2. 17β Estradiol (E2)
3.  Methanol
3. Store in freezer
BPA and 
E2 stock
Organic
Scale
2.
4.
1.  Mix 0.02 grams each of BPA and 
E2 into 200ml of methanol
Place on shaker table at level 5 for 
15 minutes
Materials Method
Solution Soution Type Materials Method
  Place on shaker table at level 5 for 
15 minutes
2.
Mix 10µl BPA and E2 stock solution 
with 1L water using syringe
3.
Aqueous
Aqueous 
sample 
preperation
BPA and E2 stock solution1.
Water type of choice (i.e. DI 
water, treated wastewater, etc.
2.
Syringe3.
Remove BPA and E2 stock solution 
from freezer
1.
Solution Soution Type
2. Methanol
3.  Store in freezer
Materials Method
Mix 0.02 grams or 22µl nonylphenol 
into 200ml of methanol
1.
NP 
Internal 
Standard
Aqueous 2. Place on shaker table at level 5 for 
15 minutesEither a scale for solid NP or 
syringe for liquid NP
3.
Nonylphenol (NP)1.
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Table 2.4: SPE method steps 
Step Method Step Objective 
1. Conditioning/ 
Equilibrate (not 
flow rate 
sensitive) 
Pull 5 mL of methanol three 
times and then 5 mL of DI 
through cartridge using 
Büchner flask under mild 
vacuum 
Conditioning Objective: To moisten pores 
in silica packing material in filter column 
with organic solvent so as to change silica 
pores from hydrophobic to hydrophilic 
and allow analyte capture. 99% of 
chromatographic surface is inside pores. 
When dry, the silica particle has a 
hydrophobic ligand which will not allow 
analyte into pore for capture.  
Equilibrate Objective: To fill pores with 
water, allowing sample in following steps 
to penetrate pores 
2. Loading (flow 
rate sensitive) 
Pull 0.5 L of 1 µg/L aqueous 
sample through cartridge at 
low flow volume using 
Büchner flask. 1 mL per 
minute is typical flow rate. 
To transfer compounds from the sample to 
the cartridge. Note: compounds are not 
solids; this is not a TSS filtration process. 
Compounds are retained in cartridge by 
chemical interactions between the sorbent 
and the compounds. 
3. Washing (flow 
rate sensitive) 
Rinse cartridge 1 time with 5 
mL of DI water using Büchner 
flask. 1 mL per minute is 
typical flow rate. 
To wash off potential interferences and to 
remain consistent with well-established 
SPE method 
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Table 2.4 (Continued) 
Step Method Step Objective 
4. Elution (flow 
rate sensitive) 
Pull 5 mL methanol through 
cartridge using vacuum 
manifold to a separate 
container. Container size 
should be compatible with 
evaporation apparatus. 1 mL 
per minute is typical flow rate. 
Objective 1: To move analytes from solid 
phase to organic phase, facilitating 
subsequent steps  
Objective 2: To transfer compounds to a 
smaller volume of fluid, thus increasing 
concentration by a factor of 100. 
5. Internal 
Standard 
Spike eluent with 5 µL of 
nonylphenol (NP) stock 
solution (22 µL NP: 200 mL 
methanol) 
This controlled amount of NP, added after 
the SPE process phase, is used in the 
analysis phase to check for potential SPE 
system errors and normalize peak area 
obtained from GC-MS 
6. Evaporation Place eluent and its container 
in evaporation apparatus and 
evaporate off organic solvent 
until just a residue remains 
(evaporate to dryness) 
To isolate just the compounds by 
removing them from the eluent 
7. Derivatization Add 100 µL of derivatization 
agent BSTFA-TMCS to dry 
sample and then placing in 
oven at 65°C for 25 min 
The derivatization step, by way of 
silylation, makes analytes more volatile 
and easier to detect using the GC-MS 
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Table 2.4 (Continued) 
Step Method Step Objective 
8. Analysis Inject 1 µL of sample into GC-
MS within 30 minutes of 
derivatization  
To analyze derivatized concentrations of 
analytes in sample 
2.5 GC-MS Method 
A PerkinElmer (Boston, MA) GC (Clarus 580) and MS (Clarus 560D) was  used in this 
analysis. The software used was Turbo Mass. 
Prior to data acquisition, the scan mode was set using the Turbo Mass software program 
to the following parameters: 
• The inlet line temperature of the GC/MS was set at 170 °C 
• The manifold source temperature was set at 160 °C 
• The oven temperature was set at maximum temperature of 280 °C 
• The electron emission current of GC/MS was 10 μA (70 eV) 
• Multiplier voltage was 366 V 
Data acquisition was performed in split scan mode measuring the following three 
compounds and their associated GC-MS specific fragment value (m/z) and typical elution times: 
Table 2.5: Analytes with fragment value and typical elution times 
 
The GC oven temperature step-up program was:  
• Hold the oven temperature for 1 min at 80°C 
• Increase the temperature by 15°C/min to 240°C 
Analyte (m/z) Typical Elution Times (min)
NP 313 12.0
BPA 357 13.5
E2 416 18.0
 12 
 
• Hold for 1 min  
• Increase the temperature by 10°C/min to 280°C 
• Hold for 10 min.  
The total run time for one sample to complete analysis in the GC-MS was programmed at 
26.67 minutes. See Figure 2.3 for an example chromatogram for BPA. 
 
Figure 2.3: Example chromatogram for BPA. 13.56 is the elution time, 357 is the fragment, and 
176,521 is the chromatogram peak area. 
 
2.6 Testing and Data Analysis Procedure for SPE Cartridges 
In order to obtain high quality data, efforts to reduce interferences from glassware were 
found to be a critical component to this study. When not in use during analysis, all glassware was 
kept in a 10% HCl acid bath. Syringes were washed throughout, and after, every sample 
preparation using methanol. 
Samples were prepared (see Section 2.3) using the SPE method (see Section 2.4) and 
analyzed using a GC-MS (see Section 2.5). Chromatograms with peak areas were obtained for 
each analyte per sample run using the GC-MS (see figure 2.3 for example). 
Chromatogram peak areas were collected for each sample. See Appendix A, Table A.1a, 
Table A.1b, and Figure A.1 for examples. 10 cartridges were used per water type. Peak area 
values for BPA and E2 were normalized by dividing the values by the areas of the internal 
standard peak area. DI water cartridges were run 20 times each. Treated wastewater cartridges 
were run 10 times each. Peak areas were evaluated and averaged across sample run number. For 
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example, BPA peak areas for sample 3 across all 10 treated wastewater cartridges were evaluated 
together for an average, sample standard deviation, and outliers. The average area for each run 
number was then plotted and evaluated for any observable trends up or trends down to indicate 
the cartridge had possibly exceeded the maximum allowable number of re-uses. 
Prior to evaluating the full data set, outliers were identified and removed using the 
Interquartile Range[26]. In order to do this, all peak areas (entire data set for NP, and per run for 
BPA and E2) for a specific water type were collected together and ordered from smallest to 
largest, then separated in half. The median of the smallest half is called the lower fourth. The 
median of the upper half is the upper fourth. A measure of spread that is resistant to outliers, the 
Fourth Spread (fs), is calculated as such: 
fs= upper fourth – lower fourth 
An observation farther than 1.5 times the Fourth Spread (1.5*fs) from the closest fourth 
(lower or upper) is considered an outlier. Peak area values that were identified as outliers using 
this method were not included in the analysis. 
The two-sided t-test with a 95% confidence was used to evaluate statistical significant 
variation between Run 1 and Run j (j=2…10 for DI water and j=2…20 for treated wastewater) 
[26]. The null hypothesis for this test stated: “Any difference in the average peak area between 
single use and “n” use is due purely to “noise” and does not indicate a change in the cartridge.” 
A t-statistic was calculated for each run number and compared to its critical value [26]. Critical 
values can be looked up in any standard critical value t distribution table. t-Static values that 
exceeded the associated critical value indicated the failure of the null hypothesis. This failure 
was used to represent a “breaking point” which indicated the possibility that the cartridge was no 
longer re-usable.  
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CHAPTER 3: RESULTS 
 
 20 samples per cartridge for deionized water, and 10 samples per cartridge for treated 
wastewater, were collected and analyzed. The following are the final plots per analyte for each 
water type: 
 
Figure 3.1: NP average peak areas per sample number for DI water 
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Table 3.1: All nonylphenol peak areas collected from DI water sample run 1 through 20 for 
cartridge 1 through 10 with outliers removed. Removed outliers are represented by an X. A dash 
(-) represents when no data was available (for example, if a test tube fractured while in the oven 
before an analysis could be performed). 
 
 
Figure 3.2: BPA average normalized peak areas per sample number for DI water 
 
 
 
 
 
 
 
 
Run C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 Average StDev
1 177,792   234,778   20,709       52,447    53,427    66,962    X X 17,950    X 8.92E+04 8.36E+04
2 133,056   191,180   47,208       51,486    20,953    113,746   X X 141,385   X 9.99E+04 6.15E+04
3 X 111,330   49,555       44,821    23,603    127,284   X 215,546    151,388   101,820   1.03E+05 6.35E+04
4 49,251    41,905    156,918      106,843   72,506    132,377   X 97,283      66,175    193,868   1.02E+05 5.12E+04
5 78,164    -          61,895       83,667    33,612    55,100    99,992      X 114,072   41,212    7.10E+04 3.54E+04
6 68,736    38,731    61,895       95,435    67,213    59,287    145,695    X 52,992    43,841    7.04E+04 3.26E+04
7 61,529    65,447    X 120,525   45,340    28,004    96,335      66,167      58,952    75,273    6.86E+04 2.71E+04
8 64,710    57,301    136,982      74,563    30,292    50,323    93,114      62,803      38,056    57,991    6.66E+04 3.04E+04
9 112,588   99,665    86,541       84,972    37,016    63,288    219,396    166,127    40,984    79,301    9.90E+04 5.62E+04
10 107,521   85,637    66,671       -          54,697    74,816    234,041    234,041    42,800    99,674    1.11E+05 7.69E+04
11 49,337    58,809    109,611      -          80,825    67,270    110,940    101,042    39,842    38,400    7.29E+04 3.57E+04
12 62,821    88,995    99,276       36,334    -         85,487    75,970      28,416      2,574      46,723    5.85E+04 3.56E+04
13 55,634    74,105    46,480       78,523    34,162    100,956   147,458    21,136      45,155    -          6.71E+04 4.23E+04
14 54,901    104,047   49,048       242,118   74,900    250,787   180,784    48,840      43,219    79,125    1.13E+05 8.12E+04
15 136,510   157,723   120,631      111,621   17,789    159,488   X X 185,547   155,025   1.31E+05 5.13E+04
16 56,542    141,619   164,471      90,948    43,179    141,250   X X 40,612    96,642    9.69E+04 4.82E+04
17 56,499    157,938   93,120       -          30,409    67,358    X 32,719      54,861    152,285   8.06E+04 5.40E+04
18 89,583    115,124   36,010       90,656    32,067    76,968    X 19,408      111,998   36,341    6.76E+04 3.69E+04
19 71,185    82,878    32,458       32,575    31,446    39,234    60,829      43,498      35,081    90,540    5.20E+04 2.26E+04
20 -          100,202   52,971       50,624    92          76,229    25,006      68,343      47,948    159,765   6.46E+04 4.78E+04
NP Outliers Excluded
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Table 3.2a: All bisphenol peak areas collected from DI water, sample run 1 through 20 for 
cartridge 1 through 10 with outliers removed. Removed outliers are represented by an X. 
Because nonylphenol is the internal standard and is used to normalize the EDC peak areas, all 
non-outlier BPA peak areas were also removed if the nonylphenol peak area from the same 
cartridge number and run number was an outlier. BPA runs with an associated NP outlier are 
highlighted in yellow. A dash (-) represents when no data was available (for example, if a test 
tube fractured while in the oven before an analysis could be performed). 
 
Table 3.2b: Average bisphenol peak areas per run, collected from DI water, and associated t-
statistic. 
 
Run C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 Average StDev
1 1.31        0.82        2.02           1.67        7.98       2.22        X 11.85      3.98           4.23           
2 1.13        0.83        3.79           12.06      10.70     12.03      1.33        5.98           5.36           
3 1.77        3.24           2.54        X 1.15        0.22         1.51        1.94        1.77           0.97           
4 X 5.12        0.54           0.72        4.71       0.62        0.66         2.40        1.17        1.99           1.90           
5 1.73        X 1.49           1.70        1.24       1.60        1.26         X 1.24        1.53        1.47           0.20           
6 13.86      8.50        2.80           X 6.73       5.69        1.10         3.64        4.90        5.90           3.96           
7 2.82        2.00        4.71        1.72       X 1.46         1.60         5.16        0.65        2.51           1.61           
8 2.13        1.20        0.76           X 1.47       2.65        1.09         1.11         1.17        1.07        1.40           0.60           
9 1.60        1.30        1.15           0.80        4.97       3.37        1.02         0.66         3.90        1.82        2.06           1.49           
10 1.50        1.69        2.12           -          2.29       3.21        1.29         0.72         0.38        1.01        1.58           0.96           
11 4.24        2.83        1.17           -          1.16       2.70        1.83         1.14         0.20        2.70        2.00           1.32           
12 2.59        1.18        1.14           5.03        -         1.57        -           0.57         -          2.31        2.06           1.57           
13 1.72        0.58        2.15           1.36        X 0.91        1.52         2.90         3.24        -          1.80           1.05           
14 0.45        1.07        1.55           0.66        2.23       0.59        1.02         X 1.45        1.25        1.14           0.56           
15 1.08        2.11        1.31           1.71        X 0.68        1.03        0.82        1.25           0.51           
16 2.82        4.73        0.57           3.27        4.67       0.61        3.33        1.05        2.63           1.70           
17 3.04        1.00        1.01           -          4.27       X 2.13         2.16        1.00        2.09           1.36           
18 3.25        1.80        4.45           0.72        5.23       5.06        2.36         1.33        2.82        3.00           1.63           
19 X 1.51        3.27           2.04        2.81       3.41        1.84         1.68         3.58        1.47        2.40           0.86           
20 -          0.25        3.41           1.06        X 3.00        1.41         2.30         2.32        0.49        1.78           1.23           
BPA Ratios Outliers Excluded
Run Average Critical value (t0.025,ѵ) 2 sided t-statistic
1 3.98           
2 5.98           2.201 0.774
3 1.77           2.447 1.351
4 1.99           2.306 1.147
5 1.47           2.447 1.569
6 5.90           2.179 0.903
7 2.51           2.365 0.866
8 1.40           2.447 1.601
9 2.06           2.365 1.154
10 1.58           2.447 1.478
11 2.00           2.447 1.202
12 2.06           2.365 1.152
13 1.80           2.447 1.337
14 1.14           2.447 1.767
15 1.25           2.447 1.701
16 2.63           2.365 0.791
17 2.09           2.365 1.136
18 3.00           2.365 0.581
19 2.40           2.447 0.974
20 1.78           2.447 1.335
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Figure 3.3: E2 average normalized peak areas per sample number for DI water 
 
Table 3.3a: All estradiol peak areas collected from DI water, sample run 1 through 20 for 
cartridge 1 through 10 with outliers removed. Removed outliers are represented by an X. 
Because nonylphenol is the internal standard and is used to normalize the EDC peak areas, all 
non-outlier E2 peak areas were also removed if the nonylphenol peak area from the same 
cartridge number and run number was an outlier. E2 runs with an associated NP outlier are 
highlighted in yellow. A dash (-) represents when no data was available (for example, if a test 
tube fractured while in the oven before an analysis could be performed). 
 
 
 
 
 
Run C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 Average StDev
1 0.22        0.21        0.24           0.29        X 0.17        X 0.23           0.04           
2 0.19        0.12        0.27           0.48        1.01       0.55        0.11        0.39           0.32           
3 0.31        0.35           0.25        X X 0.06         0.14        0.25        0.23           0.11           
4 X 0.60        0.10           0.13        0.27       0.46        0.16         0.22        0.14        0.26           0.18           
5 0.26        -          0.28           0.15        0.14       0.27        0.14         0.19        0.17        0.20           0.09           
6 X 0.60        0.24           0.87        0.40       0.40        0.09         0.21        0.21        0.38           0.25           
7 0.39        0.29        0.31        X X 0.17         0.00         0.35        0.09        0.23           0.14           
8 0.30        0.17        0.12           0.67        0.58       0.31        0.14         0.52         0.14        0.15        0.31           0.21           
9 0.22        0.64        0.19           0.14        0.65       0.51        0.10         0.11         0.31        0.21        0.31           0.21           
10 0.23        0.38        0.11           -          0.31       0.43        0.16         0.12         0.03        0.12        0.21           0.14           
11 X 0.33        0.19           -          0.32       0.35        0.26         0.11         0.03        0.26        0.23           0.13           
12 0.42        0.13        0.19           0.65        -         0.24        0.32         0.14         0.66        0.29        0.34           0.22           
13 0.21        0.68        0.37           0.20        1.01       0.13        0.20         0.55         0.44        -          0.42           0.30           
14 0.08        X 0.21           0.09        0.28       0.07        0.14         0.47         0.20        0.19        0.19           0.13           
15 0.17        0.14        0.16           0.16        X 0.07        0.16        0.07        0.13           0.04           
16 0.40        0.76        0.08           0.26        0.61       0.12        0.48        0.13        0.35           0.25           
17 0.46        0.14        0.17           -          0.56       0.96        0.24         0.28        0.10        0.36           0.30           
18 0.18        0.25        0.43           0.09        0.49       0.33        0.33         0.14        0.29        0.28           0.13           
19 0.85        0.06        0.35           1.20        0.37       X 0.23         0.27         0.48        0.20        0.45           0.36           
20 -          0.02        0.28           0.51        X X 0.20         0.36         0.29        0.06        0.25           0.18           
E2 Ratios Outliers Excluded
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Table 3.3b: Average estradiol peak areas per run, collected from DI water, and associated t-
statistic. t-Statistic values which exceed the associated critical value have been highlighted in 
yellow. 
 
 
 
Figure 3.4: NP average peak areas per sample number for treated wastewater 
 
 
 
 
Run Average Critical value (t0.025,ѵ) 2 sided t-statistic
1 0.23           
2 0.39           2.447 1.335
3 0.23           2.447 0.054
4 0.26           2.306 0.502
5 0.20           2.201 0.718
6 0.38           2.365 1.656
7 0.23           2.365 0.028
8 0.31           2.23                           1.205
9 0.31           2.23                           1.169
10 0.21           2.20                           0.326
11 0.23           2.23                           0.115
12 0.34           2.23                           1.570
13 0.42           2.26                           2.032
14 0.19           2.23                           0.723
15 0.13           2.306 3.857
16 0.35           2.365 1.422
17 0.36           2.306 1.370
18 0.28           2.23                           1.202
19 0.45           2.306 1.813
20 0.25           2.306 0.311
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Table 3.4: All nonylphenol peak areas collected from treated wastewater sample run 1 through 
10 for cartridge 11 through 20 with outliers removed. Removed outliers are represented by an X. 
A dash (-) represents when no data was available (for example, if a test tube fractured while in 
the oven before an analysis could be performed). 
 
 
 
Figure 3.5: BPA average normalized peak areas per sample number for treated wastewater 
 
Table 3.5a: All bisphenol peak areas collected from treated wastewater sample run 1 through 10 
for cartridge 11 through 20 with outliers removed. Removed outliers are represented by an X. 
Because nonylphenol is the internal standard and is used to normalize the EDC peak areas, all 
non-outlier BPA peak areas were also removed if the nonylphenol peak area from the same 
cartridge number and run number was an outlier. BPA runs with an associated NP outlier are 
highlighted in yellow. Removed outliers are represented by an X. A dash (-) represents when no 
data was available (for example, if a test tube fractured while in the oven before an analysis 
could be performed). 
 
 
 
Run C11 C12 C13 C14 C15 C16 C17 C18 C19 C20 Average StDev
1 211,659  200,002  105,911      135,982  79,627    131,424  50,040    88,791    32,803    85,118    1.12E+05 5.88E+04
2 138,152  X 145,051      112,295  133,460  127,939  64,428    41,775    85,780    79,664    1.03E+05 3.66E+04
3 137,158  223,102  57,057       91,871    163,217  115,253  37,759    68,084    91,001    87,011    1.07E+05 5.51E+04
4 176,018  186,148  62,378       113,197  78,501    58,284    89,019    55,582    66,203    49,713    9.35E+04 4.98E+04
5 128,050  96,571    97,874       133,672  185,213  144,571  77,389    71,846    -         -         1.17E+05 5.97E+04
6 72,724    118,398  98,911       128,930  138,537  134,489  86,396    83,166    47,651    77,945    9.87E+04 3.03E+04
7 93,276    189,108  104,333      61,774    182,187  108,924  94,962    88,535    49,054    94,161    1.07E+05 4.55E+04
8 154,348  173,394  125,392      132,305  66,383    92,835    120,391  127,287  -         -         1.24E+05 6.00E+04
9 116,522  151,515  137,849      89,399    73,209    91,956    92,022    X 102,887  109,490  1.07E+05 2.49E+04
10 171,916  87,328    82,825       155,109  75,637    91,999    167,231  X 148,102  107,472  1.21E+05 3.92E+04
NP Outliers Excluded
Run C11 C12 C13 C14 C15 C16 C17 C18 C19 C20 Average StDev
1 0.70       0.76       X 0.90       1.03       0.61       1.39       1.32       1.08       0.99       0.98                     0.26           
2 0.45       0.48           0.61       0.82       0.82       1.56       1.39       2.06       X 1.03                     0.58           
3 0.60       0.40       0.32           0.52       0.41       0.95       1.07       0.85       X 0.72       0.65                     0.26           
4 X 0.57       X 1.04       0.46       1.15       1.21       1.30       1.03       1.13       0.99                     0.30           
5 0.48       0.73       1.39           X 0.80       1.15       1.50       1.37       -         -         1.06                     0.58           
6 0.66       1.42       0.70           1.21       0.77       1.16       1.95       1.52       0.58       1.33       1.13                     0.45           
7 0.59       0.58       0.72           1.15       0.95       1.43       0.59       1.83       1.53       X 1.04                     0.47           
8 1.02       0.67       0.61           0.89       1.23       1.33       1.46       1.58       -         -         1.10                     0.56           
9 0.77       0.43       0.96           0.74       0.78       0.96       0.64       0.80       0.69       0.75                     0.16           
10 0.14       0.84       0.63           0.42       1.86       0.86       1.04       0.49       0.68       0.77                     0.49           
BPA Ratios Outliers Excluded
 20 
 
Table 3.5b: Average BPA peak areas per run, collected from treated wastewater, and associated 
t-statistic. t-Statistic values which exceed the associated critical value have been highlighted in 
yellow. 
 
 
 
Figure 3.6: E2 average normalized peak areas per sample number for treated wastewater 
 
 
 
 
 
 
 
 
 
Run Average Critical value (t0.025,ѵ)2 sided t-test
1 0.98                     
2 1.03                     2.262 0.221
3 0.65                     2.120 2.632
4 0.99                     2.145 0.080
5 1.06                     2.201 0.390
6 1.13                     2.145 0.915
7 1.04                     2.179 0.355
8 1.10                     2.160 0.616
9 0.75                     2.160 2.187
10 0.77                     2.179 1.097
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Table 3.6a: All estradiol peak areas collected from treated wastewater sample run 1 through 10 
for cartridge 11 through 20 with outliers removed. Removed outliers are represented by an X. 
Because nonylphenol is the internal standard and is used to normalize the EDC peak areas, all 
non-outlier E2 peak areas were also removed if the nonylphenol peak area from the same 
cartridge number and run number was an outlier. E2 runs with an associated NP outlier are 
highlighted in yellow. Removed outliers are represented by an X. A dash (-) represents when no 
data was available (for example, if a test tube fractured while in the oven before an analysis 
could be performed). 
 
 
Table 3.6b: Average E2 peak areas per run, collected from treated wastewater, and associated t-
statistic. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Run C11 C12 C13 C14 C15 C16 C17 C18 C19 C20 Average StDev
1 0.11       0.14       X X 0.17       0.10       0.21       0.19       0.11       0.13       0.14                     0.04           
2 0.08       0.07           0.10       0.15       0.15       0.26       0.24       0.33       0.30       0.19                     0.10           
3 X 0.06       0.03           0.02       0.07       0.17       0.17       0.13       X 0.12       0.10                     0.06           
4 X 0.14       0.15           0.08       0.10       0.17       0.20       0.23       0.31       0.16       0.17                     0.07           
5 0.07       0.14       0.14           0.10       0.13       0.21       0.22       0.21       -         -         0.15                     0.08           
6 X 0.16       0.23           0.18       0.16       0.20       0.21       0.21       0.08       0.20       0.18                     0.04           
7 0.14       0.09       X X 0.16       0.26       0.23       0.28       0.23       0.33       0.21                     0.08           
8 0.16       0.14       0.09           0.09       0.24       0.20       0.25       0.27       -         -         0.18                     0.10           
9 0.07       0.08       0.11           0.18       0.11       0.15       0.30       0.13       0.11       0.14                     0.07           
10 0.01       0.12       0.08           0.04       0.26       0.13       0.16       0.07       0.14       0.11                     0.07           
E2 Ratios Outliers Excluded
Run Average Critical value (t0.025,ѵ) 2 sided t-test
1 0.14                     
2 0.19                     2.228 1.20
3 0.10                     2.179 1.95
4 0.17                     2.160 1.05
5 0.15                     2.160 0.23
6 0.18                     2.131 1.87
7 0.21                     2.228 2.19
8 0.18                     2.179 1.00
9 0.14                     2.160 0.27
10 0.11                     2.179 1.05
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CHAPTER 4: DISCUSSION 
 
 Though the water samples were prepared with a consistent known concentration of 
analytes, the results showed variability in the peak area of the chromatograms (representing 
concentration). Due to the sensitivity of SPE and GC-MS analysis, this is not unusual. BPA 
contamination from plasticware, contamination from small amounts of residue build-up on 
equipment, and uneven dried sample residue are all examples of potential sources which can 
slightly alter the final results. 
 Peak area results did vary, sometime substantially. Data points deemed to be outliers 
were removed from the overall dataset (see Chapter 3 for method). Overall, however, no 
consistent trend up or down indicating steady cartridge degradation was observed. The statistical 
analysis using the t-test produced some t-statistics which were higher than the associated critical 
value, resulting in the failure of the null hypothesis and indicating a possible breaking point in 
the re-use of the cartridge. Because I was using a 95% confidence interval, there was a 5% 
chance that the null hypothesis would fail. For the most part, the number of times the null 
hypothesis failed per sample set fell within 5%. BPA in treated wastewater exceeded 5%, but the 
number of times the null hypothesis failed was not substantially greater than other sample sets so 
the percentage could be attributed to the small sample size. Additionally, no consistency or 
logical pattern in these breaking point was observed. For example, a breaking point was observed 
on run 15 for E2 in DI water. If a failure had occurred, it would be expected that at least a certain 
percentage of run 15-20 would also fail. This did not occur. Additionally, there was not a 
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particular run number that consistently failed either per water type, EDC type, or overall. 
Therefore no cartridge failure was identified. 
 Based on the results of this study, the single-use Oasis HLB cartridge appears to be 
reusable for at least 20 purified water samples with no organic matrix, and at least 10 times for 
filtered wastewater samples containing an organic matrix. As no failure of the cartridge was 
observed, and no quantifiable maximum number of re-uses was identified, re-use could exceed 
these values.  
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CHAPTER 5: SUMMARY, CONCLUSION, AND RECOMMENDATIONS 
 
 The results of this study indicate that the SPE single-use Oasis HLB cartridge is, in fact, 
re-usable to at least 20 re-uses for purified water with no organic matrix, and at least 10 re-uses 
for filtered water with an organic matrix.  
To the best of my knowledge, there is only one published study evaluating the re-use of 
single-use SPE discs. Therefore there are a number of knowledge gaps which still need to be 
filled. For example, does the manufacturer and type of SPE cartridge make a difference? Does 
the water type make a difference? I would recommend more studies be performed using multiple 
types/ manufacturers of SPE cartridges and discs using water types with a variety of organic 
matrices. If evaluation is to include a statistical analysis, does using a larger sample size better 
the approximation (based on the Central Limit Theorem [26]? Does using a larger sample size 
result in the observation of an eventual cartridge failure?) I would also recommend a studies be 
carried out until either a trend up/ down, or a breaking point, is identified to indicate quantifiable 
cartridge failure. Is there a physical/ chemical explanation for an observed failure in a cartridge? 
It may also be helpful to perform a study which focuses specifically on the materials of the 
cartridge. For instance, how does the silica of the solid phase behave over multiple cartridges re-
uses. Micro-imaging and chemical analysis could offer helpful knowledge as to why a cartridge 
would or would not fail.  
In performing this study, I found contamination prevention was a critical component to 
SPE, regardless whether or not the cartridge was being re-used or not. Unused glassware was 
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stored in an acid bath. Equipment such as the injection needle and evaporation apparatus were 
routinely cleansed with methanol. As I was analyzing for BPA, it was necessary for me to reduce 
as much plasticware in the study as possible. Otherwise, due to the sensitivity of SPE, plastic 
exposure led to spiked BPA results. 
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APPENDIX A: EXAMPLE DATA COLLECTION 
 
Table A.1a: Example collected peak area, and normalization (analyte/NP ratio column). Analyte 
here is BPA for cartridge 17, Sample 1-10. 
 
 
 
Table A.1b: Statistical evaluation of BPA for cartridge 17, Sample 1-10. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cartridge run Time BPA area Denominator BPA/NP ratio
0 0 -               
1 13.48 69,388          50,040                1.39                   
2 13.38 100,529        64,428                1.56                   
3 13.41 40,470          37,759                1.07                   
4 13.35 108,121        89,019                1.21                   
5 13.33 116,455        77,389                1.50                   
6 13.33 168,222        86,396                1.95                   
7 13.38 55,936          94,962                0.59                   
8 13.36 175,223        120,391              1.46                   
9 13.37 58,635          92,022                0.64                   
10 13.38 174,340        167,231              1.04                   
Time Area
StDv 0.04 0.40                   
Max 13.48 1.95                   
Min 13.33 0.59                   
Range 0.15 1.36                   
Average 13 1.24                   
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Figure A.1: Plot of peak area for one cartridge over all 10 re-uses. Analyte here is BPA for 
cartridge 17, Sample 1-10. 
 
